Why rich countries are hoarding smallpox vaccines
Danish pharma company has doubled its revenue projections as orders flood in
Wealthier countries are responding to the monkeypox outbreak by ordering more smallpox vaccines than they require, risking a reprise of the vaccine inequality seen during the Covid-19 pandemic.
A total of 366 confirmed monkeypox cases have been identified in the UK, and a further 275 in Spain, 209 in Portugal and 48 in the US. Rich countries are responding by “ordering more vaccines than they’ll arguably need”, said Quartz.
The vaccine attracting such interest is actually for smallpox but is estimated to provide 85% protection against monkeypox.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The US has ordered half a million doses, on top of the 1.5 million it already had stockpiled. The vaccine’s Danish maker, Bavarian Nordic, has received so many orders that it has more than doubled its revenue projections.
Last month, Bavarian Nordic said an undisclosed country had ordered sufficient doses to cover its potentially at-risk population in the short and medium term.
The company said it was also “currently in dialogue” with several other governments concerning supply of the vaccine to mitigate the current outbreak and to “explore opportunities for longer term collaboration to build stockpiles for future preparedness”.
Despite the presence of monkeypox in Africa for decades, there has been little investment into preventing and treating cases. Therefore, said Quartz, the “best option” is to use vaccines and therapeutics developed in case of a smallpox terror attack.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Last month, Dr Luigi Ferrucci, scientific director of the National Institute on Aging, told The New York Times that older adults are partially protected by distant smallpox vaccinations.
“The bottom line is that even those that were vaccinated many decades before maintain a very, very high level of antibodies and the ability to neutralise the virus,” he said. “Even if they were vaccinated 50 years ago, that protection should still be there.”
News of smallpox jabs being hoarded by wealthier countries has reignited concern about vaccine inequality. During the Covid pandemic, the World Health Organization said that the “global failure to share vaccines equitably” was “taking its toll on some of the world’s poorest and most vulnerable people” and leading to new variants of concern that meant that the risks of infection “increased in all countries for people who are not yet protected by vaccination”.
The monkeypox virus was discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research, says the UK government website’s infectious diseases portal.
Chas Newkey-Burden has been part of The Week Digital team for more than a decade and a journalist for 25 years, starting out on the irreverent football weekly 90 Minutes, before moving to lifestyle magazines Loaded and Attitude. He was a columnist for The Big Issue and landed a world exclusive with David Beckham that became the weekly magazine’s bestselling issue. He now writes regularly for The Guardian, The Telegraph, The Independent, Metro, FourFourTwo and the i new site. He is also the author of a number of non-fiction books.
-
Judges block $25B Kroger-Albertsons merger
Speed Read The proposed merger between the supermarket giants was stalled when judges overseeing two separate cases blocked the deal
By Peter Weber, The Week US Published
-
Netanyahu takes the stand in corruption trial
Speed Read He is Israel's first sitting leader to take the stand as a criminal defendant
By Rafi Schwartz, The Week US Published
-
New Syria government takes charge, urging 'stability'
Speed Read The rebel forces that ousted Syrian leader Bashar al-Assad announced an interim government
By Peter Weber, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published